Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), has announced the completion of a new sterile manufacturing facility in Nottingham, UK. This addition complements the company’s existing 50,000 sq. ft. Trent Gateway site and is specifically designed
Upperton Pharma Solutions has announced the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK. This inspection, conducted by the UK Government’s
Upperton Pharma Solutions Contract Manufacturing & Development (CDMO) Profile Upperton Pharma Solutions is a UK-based leading contract development and manufacturing organisation (CDMO) specialising in formulation development, clinical trial manufacturing and manufacturing services for a wide range of dosage forms, including
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
